Showing results (321-330 of 334) with videos related to
Sort By:
Pageof 34
Scientific Reports|April 27, 2023
Lipid-coated mesoporous silica nanoparticles for anti-viral applications via delivery of CRISPR-Cas9 ribonucleoproteinsAnnette E LaBauve, Edwin A Saada, Iris K A Jones, et al.Nature Communications|November 22, 2022
Surface faulting earthquake clustering controlled by fault and shear-zone interactionsZoë K Mildon, Gerald P Roberts, Joanna P Faure Walker, et al.Molecular Psychiatry|November 21, 2017
Nicotinic receptors mediate stress-nicotine detrimental interplay via dopamine cells' activityC Morel, S P Fernandez, F Pantouli, et al.Acta Biomaterialia|July 24, 2020
Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR deliveryAchraf Noureddine, Angelea Maestas-Olguin, Edwin A Saada, et al.Mabs|August 4, 2021
Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodiesMaxwell A Stefan, Yooli K Light, Jennifer L Schwedler, et al.Clinical Genetics|August 31, 2016
Mitochondrial epileptic encephalopathy, 3-methylglutaconic aciduria and variable complex V deficiency associated with TIMM50 mutationsM A Shahrour, O Staretz-Chacham, D Dayan, et al.Molecular Psychiatry|July 4, 2012
Co-activation of VTA DA and GABA neurons mediates nicotine reinforcementS Tolu, R Eddine, F Marti, et al.Nature|July 8, 2005
Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptorsU Maskos, B E Molles, S Pons, et al.Journal of Molecular Neuroscience : MN|December 29, 2006
Targeted in vivo expression of nicotinic acetylcholine receptors in mouse brain using lentiviral expression vectorsB E Molles, U Maskos, S Pons, et al.Frontiers in Molecular Biosciences|July 30, 2021
Discovery of Small-Molecule Inhibitors of SARS-CoV-2 Proteins Using a Computational and Experimental PipelineEdmond Y Lau, Oscar A Negrete, W F Drew Bennett, et al.Pageof 34